Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the efficacy and safety of pazopanib in combination
with lapatinib with that of lapatinib alone or pazopanib alone in subjects with metastatic
cervical cancer